Last edition
News about
Nona Biosciences, Link Cell Therapies Partner to Advance Next-Gen CAR-T Antibody Discovery
The multi-target collaboration will combine Nona Biosciences’ fully human HCAb Harbour Mice and NonaCarFx platforms with Link Cell Therapies’ cell therapy expertise to develop novel CAR-T candidates for solid and hematologic cancers.
Dr Jitendra Singh Inaugurates SAMARTH Skill Centre, iDeA-NA Tech Incubator at DBT-CDFD, Hyderabad
While inaugurating the initiatives, Dr Jitendra Singh, Union Minister of State (Independent Charge), Science & Technology, Earth Sciences, and Minister of State, PMO, Department of Space and Department of Atomic Energy, highlighted India’s transition towards futuristic healthcare, early disease detection, affordability and personalised medicine.
Novartis to Add Fourth US Radioligand Therapy Plant in Florida
Novartis will expand its US radioligand therapy manufacturing network with a new purpose-built facility in Winter Park, Florida, strengthening patient access across the southeastern US and supporting the company’s broader USD 23 billion investment in advanced manufacturing and oncology innovation.
Sophia Genetics, MD Anderson Partner to Advance AI-Driven Precision Oncology
The strategic collaboration will combine SOPHiA GENETICS’ AI-powered analytics with MD Anderson Cancer Centre’s clinical expertise to develop next-generation sequencing tools and accelerate data-driven cancer diagnosis and treatment.
23rd BioAsia to be Held from 16 to 18 Feb in Hyderabad
The Telangana government has launched BioAsia 2026, highlighting the summit’s focus on TechBio, AI and automation as key drivers reshaping life sciences, healthcare innovation and global health systems.
Just-Evotec Biologics Secures Gates Foundation Grant to Expand Global Access to Biotherapeutics
The funding will support ten new molecular design projects over three years, leveraging Just-Evotec Biologics’ J.MD computational platform to optimise monoclonal antibodies and other biologics, reduce development costs and improve access to affordable therapies for infectious diseases in low- and middle-income countries.
Pfizer Reports Improved Response Rates with BRAFTOVI Regimen in Metastatic Colorectal Cancer
New data from the BREAKWATER study show that Pfizer’s BRAFTOVI-based regimen significantly improved response rates in patients with BRAF V600E–mutant metastatic colorectal cancer, supporting the potential use of flexible chemotherapy backbones.
Organon to Market Bempedoic Acid Therapy Nilemdo in Key European Markets
Organon, a global healthcare company focused on delivering impactful medicines and solutions for everyday health, has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo (bempedoic acid) across France, Denmark, Iceland, Sweden, Finland, and Norway.
PharmaForceIQ Strengthens AI Capabilities with Aktana Acquisition
PharmaForceIQ, an end-to-end, real-time customer engagement platform for the pharmaceutical industry, has announced the acquisition of Aktana, integrating its digital commercialization platform with Aktana’s artificial intelligence-driven field next-best-action (NBA) technology.
Merck Explores USD 28-32 Billion Buyout of Oncology Biotech Revolution Medicines
Merck & Co. is in discussions to acquire U.S.-based oncology biotech Revolution Medicines in a deal that could value the company between USD 28 billion and USD 32 billion, according to people familiar with the matter.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy